88 related articles for article (PubMed ID: 15949532)
41. Role of Cripto-1 in stem cell maintenance and malignant progression.
Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
[TBL] [Abstract][Full Text] [Related]
42. Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells.
Watanabe K; Meyer MJ; Strizzi L; Lee JM; Gonzales M; Bianco C; Nagaoka T; Farid SS; Margaryan N; Hendrix MJ; Vonderhaar BK; Salomon DS
Stem Cells; 2010 Aug; 28(8):1303-14. PubMed ID: 20549704
[TBL] [Abstract][Full Text] [Related]
43. Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1.
Watanabe K; Nagaoka T; Lee JM; Bianco C; Gonzales M; Castro NP; Rangel MC; Sakamoto K; Sun Y; Callahan R; Salomon DS
J Cell Biol; 2009 Nov; 187(3):343-53. PubMed ID: 19948478
[TBL] [Abstract][Full Text] [Related]
44. Cripto-1 is required for hypoxia to induce cardiac differentiation of mouse embryonic stem cells.
Bianco C; Cotten C; Lonardo E; Strizzi L; Baraty C; Mancino M; Gonzales M; Watanabe K; Nagaoka T; Berry C; Arai AE; Minchiotti G; Salomon DS
Am J Pathol; 2009 Nov; 175(5):2146-58. PubMed ID: 19834060
[TBL] [Abstract][Full Text] [Related]
45. Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.
di Bari MG; Ginsburg E; Plant J; Strizzi L; Salomon DS; Vonderhaar BK
J Cell Physiol; 2009 Jun; 219(3):659-66. PubMed ID: 19170109
[TBL] [Abstract][Full Text] [Related]
46. Activation of a Nodal-independent signaling pathway by Cripto-1 mutants with impaired activation of a Nodal-dependent signaling pathway.
Bianco C; Mysliwiec M; Watanabe K; Mancino M; Nagaoka T; Gonzales M; Salomon DS
FEBS Lett; 2008 Dec; 582(29):3997-4002. PubMed ID: 19013461
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the glycosylphosphatidylinositol-anchor signal sequence of human Cryptic with a hydrophilic extension.
Watanabe K; Nagaoka T; Strizzi L; Mancino M; Gonzales M; Bianco C; Salomon DS
Biochim Biophys Acta; 2008 Dec; 1778(12):2671-81. PubMed ID: 18930707
[TBL] [Abstract][Full Text] [Related]
48. Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300.
Hirota M; Watanabe K; Hamada S; Sun Y; Strizzi L; Mancino M; Nagaoka T; Gonzales M; Seno M; Bianco C; Salomon DS
Cell Signal; 2008 Sep; 20(9):1632-41. PubMed ID: 18595660
[TBL] [Abstract][Full Text] [Related]
49. Activins and activin antagonists in hepatocellular carcinoma.
Deli A; Kreidl E; Santifaller S; Trotter B; Seir K; Berger W; Schulte-Hermann R; Rodgarkia-Dara C; Grusch M
World J Gastroenterol; 2008 Mar; 14(11):1699-709. PubMed ID: 18350601
[TBL] [Abstract][Full Text] [Related]
50. Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.
Bianco C; Strizzi L; Mancino M; Watanabe K; Gonzales M; Hamada S; Raafat A; Sahlah L; Chang C; Sotgia F; Normanno N; Lisanti M; Salomon DS
Am J Pathol; 2008 Feb; 172(2):345-57. PubMed ID: 18202186
[TBL] [Abstract][Full Text] [Related]
51. beta-Catenin/TCF/LEF regulate expression of the short form human Cripto-1.
Hamada S; Watanabe K; Hirota M; Bianco C; Strizzi L; Mancino M; Gonzales M; Salomon DS
Biochem Biophys Res Commun; 2007 Mar; 355(1):240-4. PubMed ID: 17291450
[TBL] [Abstract][Full Text] [Related]
52. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
Gray PC; Shani G; Aung K; Kelber J; Vale W
Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
[TBL] [Abstract][Full Text] [Related]
53. Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia.
Salomon DS; Bianco C; De Santis M
Bioessays; 1999 Jan; 21(1):61-70. PubMed ID: 10070255
[TBL] [Abstract][Full Text] [Related]
54. Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.
Bianco C; Normanno N; De Luca A; Maiello MR; Wechselberger C; Sun Y; Khan N; Adkins H; Sanicola M; Vonderhaar B; Cohen B; Seno M; Salomon D
J Cell Physiol; 2002 Jan; 190(1):74-82. PubMed ID: 11807813
[TBL] [Abstract][Full Text] [Related]
55. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.
Wechselberger C; Strizzi L; Kenney N; Hirota M; Sun Y; Ebert A; Orozco O; Bianco C; Khan NI; Wallace-Jones B; Normanno N; Adkins H; Sanicola M; Salomon DS
Oncogene; 2005 Jun; 24(25):4094-105. PubMed ID: 15897912
[TBL] [Abstract][Full Text] [Related]
56. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS
J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661
[TBL] [Abstract][Full Text] [Related]
57. Cripto-1: an oncofetal gene with many faces.
Bianco C; Strizzi L; Normanno N; Khan N; Salomon DS
Curr Top Dev Biol; 2005; 67():85-133. PubMed ID: 15949532
[TBL] [Abstract][Full Text] [Related]
58. The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.
Saloman DS; Bianco C; Ebert AD; Khan NI; De Santis M; Normanno N; Wechselberger C; Seno M; Williams K; Sanicola M; Foley S; Gullick WJ; Persico G
Endocr Relat Cancer; 2000 Dec; 7(4):199-226. PubMed ID: 11174844
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
